August 8, 2022
Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology
July 25, 2022
Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for Omicron BA.1 Adapted Bivalent Vaccine Candidate
July 11, 2022
Pfizer Canada and Rethink Breast Cancer Announce Recipients of 2022 Quality Improvement Grants Focused on Metastatic Breast Cancer
No current content.